Previous studies showed that harmalol treatment induced apoptosis of lung and liver cancer cells by activating caspase-8, caspase-3, and p53 (52, 53), indicating a potential antitumorous role of harmalol for OS. The gene discussed is TP53; the disease is liver cancer.